ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 225 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2019. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,157,364 | -48.6% | 468,597 | -50.7% | 0.00% | -33.3% |
| Q2 2023 | $11,971,878 | -42.1% | 950,149 | -40.0% | 0.01% | -50.0% |
| Q1 2023 | $20,665,614 | +11.9% | 1,583,572 | +51.3% | 0.01% | +9.1% |
| Q4 2022 | $18,467,544 | +38.6% | 1,046,913 | +19.7% | 0.01% | +37.5% |
| Q3 2022 | $13,322,000 | +45.5% | 874,756 | +41.6% | 0.01% | +60.0% |
| Q2 2022 | $9,159,000 | -41.3% | 617,615 | -10.9% | 0.01% | -28.6% |
| Q1 2022 | $15,609,000 | +114.7% | 693,113 | +75.9% | 0.01% | +133.3% |
| Q4 2021 | $7,271,000 | +16.7% | 394,093 | -15.4% | 0.00% | 0.0% |
| Q3 2021 | $6,228,000 | -11.1% | 465,766 | +23.1% | 0.00% | 0.0% |
| Q2 2021 | $7,006,000 | -30.4% | 378,501 | -43.5% | 0.00% | -40.0% |
| Q1 2021 | $10,063,000 | +65.2% | 670,246 | +58.9% | 0.01% | +25.0% |
| Q4 2020 | $6,092,000 | +31.5% | 421,806 | -25.9% | 0.00% | +33.3% |
| Q3 2020 | $4,633,000 | +19.9% | 569,189 | -0.3% | 0.00% | 0.0% |
| Q2 2020 | $3,864,000 | -6.0% | 570,841 | -2.3% | 0.00% | -25.0% |
| Q1 2020 | $4,112,000 | +39.2% | 583,986 | +94.0% | 0.00% | +100.0% |
| Q4 2019 | $2,953,000 | -17.7% | 301,077 | -7.9% | 0.00% | 0.0% |
| Q3 2019 | $3,589,000 | -46.7% | 326,946 | -43.6% | 0.00% | -50.0% |
| Q2 2019 | $6,735,000 | -5.4% | 579,371 | -22.4% | 0.00% | 0.0% |
| Q1 2019 | $7,116,000 | +7.0% | 746,258 | +8.1% | 0.00% | -20.0% |
| Q4 2018 | $6,651,000 | -85.5% | 690,158 | -78.6% | 0.01% | -61.5% |
| Q3 2018 | $45,879,000 | -7.9% | 3,219,775 | -22.4% | 0.01% | -7.1% |
| Q2 2018 | $49,791,000 | +194.2% | 4,149,411 | +202.7% | 0.01% | +75.0% |
| Q1 2018 | $16,925,000 | -32.8% | 1,370,736 | -20.8% | 0.01% | -50.0% |
| Q4 2017 | $25,179,000 | +27.7% | 1,730,780 | +24.9% | 0.02% | +14.3% |
| Q3 2017 | $19,717,000 | -27.8% | 1,385,758 | -35.2% | 0.01% | -26.3% |
| Q2 2017 | $27,294,000 | +12.8% | 2,139,288 | +12.1% | 0.02% | +5.6% |
| Q1 2017 | $24,201,000 | +68.3% | 1,908,848 | +35.5% | 0.02% | +50.0% |
| Q4 2016 | $14,382,000 | -25.8% | 1,408,672 | -4.2% | 0.01% | -14.3% |
| Q3 2016 | $19,372,000 | +21.3% | 1,471,037 | +16.9% | 0.01% | +27.3% |
| Q2 2016 | $15,972,000 | +9.2% | 1,257,879 | +13.6% | 0.01% | 0.0% |
| Q1 2016 | $14,628,000 | -19.6% | 1,107,532 | -6.4% | 0.01% | -15.4% |
| Q4 2015 | $18,190,000 | +56.8% | 1,182,837 | +26.4% | 0.01% | +44.4% |
| Q3 2015 | $11,599,000 | -28.0% | 935,609 | -20.6% | 0.01% | -10.0% |
| Q2 2015 | $16,117,000 | -21.5% | 1,178,375 | -31.4% | 0.01% | -23.1% |
| Q1 2015 | $20,530,000 | +15.0% | 1,716,880 | +22.8% | 0.01% | +18.2% |
| Q4 2014 | $17,845,000 | +21.5% | 1,397,586 | +27.6% | 0.01% | +22.2% |
| Q3 2014 | $14,687,000 | -8.3% | 1,094,956 | +9.7% | 0.01% | -18.2% |
| Q2 2014 | $16,018,000 | -10.5% | 998,184 | +0.5% | 0.01% | -15.4% |
| Q1 2014 | $17,903,000 | +0.5% | 993,053 | -13.9% | 0.01% | 0.0% |
| Q4 2013 | $17,822,000 | -2.9% | 1,152,864 | -6.6% | 0.01% | -7.1% |
| Q3 2013 | $18,346,000 | – | 1,233,942 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |